X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4482) 4482
Book Review (1229) 1229
Publication (401) 401
Newspaper Article (28) 28
Book Chapter (20) 20
Newsletter (20) 20
Conference Proceeding (16) 16
Book / eBook (15) 15
Magazine Article (12) 12
Dissertation (10) 10
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4123) 4123
index medicus (3999) 3999
female (3979) 3979
endometrial cancer (2466) 2466
middle aged (2058) 2058
oncology (1939) 1939
cancer (1522) 1522
aged (1485) 1485
adult (1409) 1409
risk factors (1370) 1370
obstetrics & gynecology (974) 974
endometrial neoplasms - pathology (901) 901
risk (798) 798
breast-cancer (732) 732
women (726) 726
endometrial neoplasms - epidemiology (676) 676
carcinoma (658) 658
health aspects (636) 636
research (624) 624
postmenopausal women (567) 567
breast cancer (538) 538
endometrial neoplasms - prevention & control (535) 535
prevention (499) 499
endometrial neoplasms - genetics (487) 487
case-control studies (486) 486
aged, 80 and over (481) 481
prognosis (470) 470
abridged index medicus (432) 432
endometrial neoplasms - chemically induced (423) 423
neoplasm staging (419) 419
ovarian cancer (416) 416
male (404) 404
epidemiology (386) 386
animals (381) 381
incidence (374) 374
endometrial neoplasms - surgery (373) 373
retrospective studies (366) 366
care and treatment (365) 365
estrogen (358) 358
public, environmental & occupational health (358) 358
obstetrics and gynecology (344) 344
endometrial neoplasms - etiology (338) 338
surgery (336) 336
article (335) 335
tamoxifen (334) 334
endometrium (333) 333
analysis (328) 328
hormone replacement therapy (324) 324
obesity (324) 324
endometrial neoplasms - diagnosis (318) 318
oncology, experimental (317) 317
breast neoplasms - drug therapy (315) 315
tamoxifen - adverse effects (304) 304
endometrial neoplasms - metabolism (302) 302
postmenopause (301) 301
breast neoplasms - prevention & control (300) 300
follow-up studies (296) 296
prospective studies (295) 295
tumors (294) 294
menopause (288) 288
diagnosis (285) 285
hematology, oncology and palliative medicine (282) 282
cohort studies (278) 278
body mass index (277) 277
endometrial carcinoma (275) 275
tamoxifen - therapeutic use (275) 275
expression (266) 266
hysterectomy (266) 266
treatment outcome (265) 265
mortality (260) 260
medicine & public health (256) 256
risk assessment (255) 255
genetic aspects (253) 253
ovarian-cancer (252) 252
health risk assessment (246) 246
endometrium - pathology (239) 239
therapy (231) 231
estrogen replacement therapy - adverse effects (229) 229
endometrial neoplasms - drug therapy (226) 226
immunohistochemistry (226) 226
breast neoplasms - epidemiology (224) 224
colorectal-cancer (224) 224
genetic predisposition to disease (223) 223
mutation (221) 221
young adult (217) 217
endometrial neoplasms (216) 216
endometrial neoplasms - mortality (215) 215
cell line, tumor (209) 209
colorectal cancer (208) 208
adenocarcinoma (207) 207
survival (199) 199
pathology (198) 198
womens health (197) 197
chemotherapy (196) 196
adolescent (195) 195
medicine (191) 191
medicine, general & internal (191) 191
nonpolyposis colorectal-cancer (187) 187
cervical cancer (182) 182
microsatellite instability (180) 180
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4389) 4389
French (51) 51
German (41) 41
Russian (20) 20
Italian (19) 19
Chinese (14) 14
Spanish (13) 13
Polish (7) 7
Czech (5) 5
Japanese (5) 5
Bulgarian (4) 4
Hungarian (4) 4
Norwegian (4) 4
Swedish (4) 4
Dutch (3) 3
Danish (2) 2
Korean (2) 2
Portuguese (2) 2
Finnish (1) 1
Serbian (1) 1
Slovenian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CA Cancer Journal for Clinicians, ISSN 0007-9235, 03/2017, Volume 67, Issue 2, pp. 100 - 121
Journal Article
British Journal of Surgery, ISSN 0007-1323, 11/2018, Volume 105, Issue 12, pp. 1650 - 1657
Obesity affects cancer risk 
MORTALITY | TRIAL | SURGERY | GASTRIC BYPASS-SURGERY | METAANALYSIS | REFLUX | BARIATRIC SURGERY | ESOPHAGEAL ADENOCARCINOMA | Esophageal Neoplasms - etiology | Neoplasms, Hormone-Dependent - mortality | Postoperative Complications - etiology | Neoplasms - etiology | Endometrial Neoplasms - mortality | Bariatric Surgery - statistics & numerical data | Humans | Middle Aged | Breast Neoplasms - etiology | Postoperative Complications - prevention & control | Prostatic Neoplasms - etiology | Esophageal Neoplasms - prevention & control | Male | Neoplasms - prevention & control | Postoperative Complications - mortality | Endometrial Neoplasms - prevention & control | Young Adult | Colorectal Neoplasms - etiology | Aged, 80 and over | Esophageal Neoplasms - mortality | Adult | Female | Obesity - mortality | Prostatic Neoplasms - prevention & control | Neoplasms, Hormone-Dependent - prevention & control | Colorectal Neoplasms - mortality | Obesity - surgery | Obesity - complications | Risk Factors | Endometrial Neoplasms - etiology | Kaplan-Meier Estimate | Colorectal Neoplasms - prevention & control | Neoplasms - mortality | Prostatic Neoplasms - mortality | Breast Neoplasms - prevention & control | Propensity Score | Neoplasms, Hormone-Dependent - etiology | Adolescent | Bariatric Surgery - mortality | Breast Neoplasms - mortality | Aged | Obesity | Surgery | Oncology, Experimental | Colorectal cancer | Hormones | Research | Health aspects | Risk factors | Cancer | Gastrointestinal surgery | Health risk assessment | Prostate | Index Medicus | Abridged Index Medicus
Journal Article
American Journal of Epidemiology, ISSN 0002-9262, 2010, Volume 172, Issue 1, pp. 21 - 35
Low vitamin D status is common globally and is associated with multiple disease outcomes. Understanding the correlates of vitamin D status will help guide... 
Body mass index | Exercise | Diet | Vitamin D | Cohort studies | Dietary supplements | Ethnic groups | Seasons | Endometrial Neoplasms - ethnology | Stomach Neoplasms - ethnology | United States - epidemiology | Kidney Neoplasms - epidemiology | Pancreatic Neoplasms - epidemiology | Prospective Studies | Vitamin D Deficiency - complications | Humans | Esophageal Neoplasms - ethnology | Esophageal Neoplasms - prevention & control | Male | Neoplasms - prevention & control | Kidney Neoplasms - prevention & control | Case-Control Studies | Endometrial Neoplasms - prevention & control | Esophageal Neoplasms - epidemiology | Ovarian Neoplasms - ethnology | Neoplasms - ethnology | Lymphoma, Non-Hodgkin - prevention & control | Lymphoma, Non-Hodgkin - ethnology | Adult | Female | Stomach Neoplasms - epidemiology | Pancreatic Neoplasms - prevention & control | Kidney Neoplasms - ethnology | Ovarian Neoplasms - prevention & control | Risk Factors | Logistic Models | China - epidemiology | Endometrial Neoplasms - epidemiology | Lymphoma, Non-Hodgkin - epidemiology | Ovarian Neoplasms - epidemiology | Vitamin D - blood | Vitamin D Deficiency - ethnology | Vitamin D Deficiency - prevention & control | Analysis of Variance | Vitamin D Deficiency - epidemiology | Stomach Neoplasms - prevention & control | Vitamin D - therapeutic use | Finland - epidemiology | Pancreatic Neoplasms - ethnology | Cohort Studies | Vitamin D deficiency | Complications and side effects | Calcifediol | Alfacalcidol | Seasonal variations (Diseases) | Research | Health aspects | Risk factors | Vitamin deficiency | Minority & ethnic groups | Index Medicus | seasons | Original Contributions | body mass index | vitamin D | ethnic groups | cohort studies | dietary supplements | exercise | diet
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2006, Volume 354, Issue 3, pp. 261 - 269
Journal Article
American Journal of Epidemiology, ISSN 0002-9262, 2010, Volume 172, Issue 1, pp. 4 - 9
The Cohort Consortium Vitamin D Pooling Project of Rarer Cancers (VDPP) brought together 10 cohorts to conduct a prospective study of the association between... 
Case-control studies | Prospective studies | Vitamin D | Neoplasms | TRIAL | LUNG-CANCER | BETA-CAROTENE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | vitamin D | prospective studies | RISK | neoplasms | ESOPHAGEAL | case-control studies | United States - epidemiology | Kidney Neoplasms - epidemiology | Pancreatic Neoplasms - epidemiology | Prospective Studies | Vitamin D Deficiency - complications | Humans | Esophageal Neoplasms - prevention & control | Male | Neoplasms - prevention & control | Kidney Neoplasms - prevention & control | Case-Control Studies | Endometrial Neoplasms - prevention & control | Esophageal Neoplasms - epidemiology | Lymphoma, Non-Hodgkin - prevention & control | Adult | Female | Stomach Neoplasms - epidemiology | Pancreatic Neoplasms - prevention & control | Ovarian Neoplasms - prevention & control | Risk Factors | China - epidemiology | Endometrial Neoplasms - epidemiology | Lymphoma, Non-Hodgkin - epidemiology | Ovarian Neoplasms - epidemiology | Vitamin D - blood | Vitamin D Deficiency - prevention & control | Vitamin D Deficiency - epidemiology | Stomach Neoplasms - prevention & control | Vitamin D - therapeutic use | Finland - epidemiology | Cohort Studies | Oncology, Experimental | Calcifediol | Alfacalcidol | Research | Health aspects | Risk factors | Cancer | Consortia | Vitamin deficiency | Oncology | Meta-analysis | Index Medicus | Original Contributions
Journal Article
INTERNATIONAL JOURNAL OF CANCER, ISSN 0020-7136, 02/2001, Volume 91, Issue 3, pp. 421 - 430
Journal Article
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2017, Volume 216, Issue 6, pp. 580.e1 - 580.e9
Journal Article
Cancer Prevention Research, ISSN 1940-6207, 06/2010, Volume 3, Issue 6, pp. 696 - 706
The selective estrogen-receptor modulator (SERM) tamoxifen became the first U. S. Food and Drug Administration (FDA)-approved agent for reducing breast cancer... 
WOMEN | RISK-FACTORS | ONCOLOGY | ESTROGEN | FOLLOW-UP | OUTCOMES | MUTATIONS | NSABP | Uterus - pathology | Raloxifene Hydrochloride - adverse effects | Raloxifene Hydrochloride - pharmacology | Adenocarcinoma - pathology | Raloxifene Hydrochloride - therapeutic use | Cataract - chemically induced | Follow-Up Studies | Thromboembolism - chemically induced | Fractures, Spontaneous - epidemiology | Estrogens | Humans | Middle Aged | Osteoporosis, Postmenopausal - complications | Endometrial Neoplasms - chemically induced | Selective Estrogen Receptor Modulators - adverse effects | Risk | Cataract - epidemiology | Thromboembolism - epidemiology | Drug Utilization | Incidence | Selective Estrogen Receptor Modulators - therapeutic use | Aged, 80 and over | Adult | Female | Osteoporosis, Postmenopausal - prevention & control | Breast Neoplasms - epidemiology | Myocardial Ischemia - epidemiology | Neoplasms, Hormone-Dependent - prevention & control | Double-Blind Method | Neoplasm Invasiveness | Myocardial Ischemia - prevention & control | Fractures, Spontaneous - etiology | Endometrial Neoplasms - epidemiology | Neoplasms, Hormone-Dependent - epidemiology | Breast Neoplasms - prevention & control | Adenocarcinoma - prevention & control | Fractures, Spontaneous - prevention & control | Breast Neoplasms - pathology | Neoplasms, Hormone-Dependent - pathology | Tamoxifen - therapeutic use | Tamoxifen - pharmacology | Aged | Tamoxifen - adverse effects | Adenocarcinoma - epidemiology | Selective Estrogen Receptor Modulators - pharmacology | Index Medicus
Journal Article
American Journal of Epidemiology, ISSN 0002-9262, 2010, Volume 172, Issue 1, pp. 10 - 20
The Cohort Consortium Vitamin D Pooling Project of Rarer Cancers (VDPP), a consortium of 10 prospective cohort studies from the United States, Finland, and... 
Case-control studies | Prospective studies | Vitamin D | Methods | Neoplasms | Cohort studies | methods | vitamin D | D DEFICIENCY | MORTALITY-RATES | OVARIAN-CANCER | BASE-LINE CHARACTERISTICS | US WOMEN | BREAST-CANCER | MALE SMOKERS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | prospective studies | PROSTATE-CANCER | cohort studies | SERUM 25-HYDROXYVITAMIN-D | neoplasms | POSTMENOPAUSAL WOMEN | case-control studies | United States - epidemiology | Meta-Analysis as Topic | Kidney Neoplasms - epidemiology | Pancreatic Neoplasms - epidemiology | Prospective Studies | Vitamin D Deficiency - complications | Humans | Esophageal Neoplasms - prevention & control | Male | Neoplasms - prevention & control | Kidney Neoplasms - prevention & control | Case-Control Studies | Endometrial Neoplasms - prevention & control | Esophageal Neoplasms - epidemiology | Lymphoma, Non-Hodgkin - prevention & control | Adult | Female | Stomach Neoplasms - epidemiology | Pancreatic Neoplasms - prevention & control | Ovarian Neoplasms - prevention & control | Risk Factors | Logistic Models | China - epidemiology | Endometrial Neoplasms - epidemiology | Lymphoma, Non-Hodgkin - epidemiology | Ovarian Neoplasms - epidemiology | Vitamin D - blood | Vitamin D Deficiency - prevention & control | Vitamin D Deficiency - epidemiology | Stomach Neoplasms - prevention & control | Vitamin D - therapeutic use | Finland - epidemiology | Research Design | Cohort Studies | Oncology, Experimental | Calcifediol | Alfacalcidol | Research | Health aspects | Risk factors | Cancer | Consortia | Research methodology | Meta-analysis | Index Medicus | Original Contributions
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2007, Volume 107, Issue 2, pp. 159 - 162
Journal Article
European Journal of Cancer, ISSN 0959-8049, 10/2017, Volume 84, pp. 60 - 68
We aimed to assess the overall cancer risk among contemporary menopausal hormone therapy (MHT) users in Sweden and the risk for different cancer types. A... 
Oestrogen replacement therapy | Genital neoplasms | Digestive system neoplasms | Menopause | Female | Hormone replacement therapy | Breast neoplasms | Neoplasms | UNITED-STATES | METAANALYSIS | HYSTERECTOMY | SWEDISH WOMEN | SYMPTOMS | ESOPHAGEAL | BREAST-CANCER | ONCOLOGY | REPLACEMENT THERAPY | REPRODUCTIVE FACTORS | HEALTH | Humans | Middle Aged | Progestins - adverse effects | Endometrial Neoplasms - chemically induced | Neoplasms - prevention & control | Neoplasms - diagnosis | Estrogens - adverse effects | Incidence | Protective Factors | Neoplasms - chemically induced | Time Factors | Drug Compounding | Adult | Registries | Breast Neoplasms - epidemiology | Digestive System Neoplasms - epidemiology | Drug Administration Schedule | Risk Assessment | Risk Factors | Digestive System Neoplasms - prevention & control | Endometrial Neoplasms - epidemiology | Sweden - epidemiology | Estrogen Replacement Therapy - adverse effects | Ovarian Neoplasms - epidemiology | Progestins - administration & dosage | Aged | Ovarian Neoplasms - chemically induced | Breast Neoplasms - chemically induced | Estrogens - administration & dosage | Neoplasms - epidemiology | Care and treatment | Health aspects | Risk factors | Cancer | Hormone therapy | Oncology, Experimental | Estrogen | Research | Therapy | Ovarian carcinoma | Invasiveness | Liver | Health risks | Population studies | Breast cancer | Ovarian cancer | Esophagus | Confidence intervals | Progestin | Colon | Endometrium | Tumors | Index Medicus
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 12/2008, Volume 100, Issue 23, pp. 1672 - 1694
Journal Article